Cargando…

Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects

BACKGROUND: The elevated level of plasminogen activator inhibitor-1 (PAI-1) in obese subjects with metabolic syndrome and in patients with type 2 diabetes is well established. The association of plasma PAI-1 and lipid metabolism is still unclear. The aim of the present study was to determine the rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Somodi, Sándor, Seres, Ildikó, Lőrincz, Hajnalka, Harangi, Mariann, Fülöp, Péter, Paragh, György
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998167/ https://www.ncbi.nlm.nih.gov/pubmed/30002679 http://dx.doi.org/10.1155/2018/9596054

Ejemplares similares

Gender-Dependent Associations between Serum Betatrophin Levels and Lipoprotein Subfractions in Diabetic and Nondiabetic Obese Patients
por: Lőrincz, Hajnalka, et al.
Publicado: (2023)

Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients
por: Szentpéteri, Anita, et al.
Publicado: (2018)

Low Levels of Serum Fetuin-A and Retinol-Binding Protein 4 Correlate with Lipoprotein Subfractions in Morbid Obese and Lean Non-Diabetic Subjects
por: Lőrincz, Hajnalka, et al.
Publicado: (2021)

Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients
por: Fülöp, Péter, et al.
Publicado: (2014)

Impaired Organokine Regulation in Non-Diabetic Obese Subjects: Halfway to the Cardiometabolic Danger Zone
por: Lőrincz, Hajnalka, et al.
Publicado: (2023)

Afamin Levels and Their Correlation with Oxidative and Lipid Parameters in Non-diabetic, Obese Patients
por: Juhász, Imre, et al.
Publicado: (2022)

Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions
por: Juhász, Lilla, et al.
Publicado: (2023)

Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity
por: Lőrincz, Hajnalka, et al.
Publicado: (2023)

High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus
por: Gaál, Krisztina, et al.
Publicado: (2016)

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
por: Varga, Viktória E., et al.
Publicado: (2016)

The Impact of Obesity on the Cardiovascular System
por: Csige, Imre, et al.
Publicado: (2018)

The Potential Diagnostic and Predictive Role of HbA1c in Diabetic, Septic Patients: A Retrospective Single-Center Study
por: Juhász, Imre, et al.
Publicado: (2022)

The profile of HDL-C subfractions and their association with cardiovascular risk in the Hungarian general and Roma populations
por: Piko, Peter, et al.
Publicado: (2022)

Association of HDL Subfraction Profile with the Progression of Insulin Resistance
por: Piko, Peter, et al.
Publicado: (2023)

Changes in serum pigment epithelium-derived factor levels after kidney transplantation in patients with end-stage renal disease
por: Szentimrei, Réka, et al.
Publicado: (2022)

Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy
por: Nádró, Bíborka, et al.
Publicado: (2021)

Sphingosine 1-Phosphate and Apolipoprotein M Levels and Their Correlations with Inflammatory Biomarkers in Patients with Untreated Familial Hypercholesterolemia
por: Juhász, Lilla, et al.
Publicado: (2022)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
por: Csiha, Sára, et al.
Publicado: (2023)

Assessment of Associations Between Serum Lipoprotein (a) Levels and Atherosclerotic Vascular Diseases in Hungarian Patients With Familial Hypercholesterolemia Using Data Mining and Machine Learning
por: Németh, Ákos, et al.
Publicado: (2022)

Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia
por: Berta, Eszter, et al.
Publicado: (2022)

Association of HDL subfraction profile with the progression of insulin resistance
por: Pikó, P, et al.
Publicado: (2023)

Association of HDL subfractions with cardiovascular risk in Hungarian general and Roma populations
por: Pikó, P, et al.
Publicado: (2022)

Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia
por: Paragh, György, et al.
Publicado: (2022)

Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia
por: Nádró, Bíborka, et al.
Publicado: (2022)

Identifying Patients with Familial Chylomicronemia Syndrome Using FCS Score-Based Data Mining Methods
por: Németh, Ákos, et al.
Publicado: (2022)

Serum Cystatin C Is a Determinant of Paraoxonase Activity in Hemodialyzed and Renal Transplanted Patients
por: Varga, Éva, et al.
Publicado: (2009)

Increased hair selenium concentration in hyperlipidemic patients
por: Fülöp, Péter, et al.
Publicado: (2013)

Role of Altered Metabolism of Triglyceride-Rich Lipoprotein Particles in the Development of Vascular Dysfunction in Systemic Lupus Erythematosus
por: Diószegi, Ágnes, et al.
Publicado: (2023)

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches
por: Nikolic, Dragana, et al.
Publicado: (2013)

Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology
por: Czókolyová, Monika, et al.
Publicado: (2021)

Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects
por: Cartolano, Flávia De C., et al.
Publicado: (2017)

Lipoprotein subfraction patterns throughout gestation in The Gambia: changes in subfraction composition and their relationships with infant birth weights
por: Woo, Jessica G., et al.
Publicado: (2023)

Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile
por: Corey, Kathleen E, et al.
Publicado: (2014)

Potential Impact on Lipoprotein Subfractions in Type 2 Diabetes
por: Kamijo, Yuka, et al.
Publicado: (2019)

Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan
por: Hsu, Hung, et al.
Publicado: (2019)

Follow-up Study of Microflora Changes in Crevicular Gingival Fluid in Obese Subjects After Bariatric Surgery
por: Balogh, Bettina, et al.
Publicado: (2020)

The Impact of Lipoprotein Apheresis on Oxidative Stress Biomarkers and High-Density Lipoprotein Subfractions
por: Mickiewicz, Agnieszka, et al.
Publicado: (2020)

Intercorrelations of lipoprotein subfractions and their covariation with lifestyle factors in healthy men
por: Parlesak, Alexandr, et al.
Publicado: (2014)

Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
por: Poropat Flerin, Tadeja, et al.
Publicado: (2022)

Association of CETP Gene Polymorphisms and Haplotypes with Cardiovascular Risk
por: Piko, Peter, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sn7kip9fp6q0hoe3rkl9hv39hf